Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Free Cash Flow (2019 - 2025)

Outset Medical (OM) has disclosed Free Cash Flow for 7 consecutive years, with -$9.7 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 41.06% to -$9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$47.1 million through Dec 2025, up 59.8% year-over-year, with the annual reading at -$47.1 million for FY2025, 59.8% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$9.7 million at Outset Medical, down from -$6.5 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$5.1 million in Q2 2025, with the low at -$46.3 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$29.0 million, with a median of -$31.0 million recorded in 2021.
  • The sharpest move saw Free Cash Flow tumbled 96.59% in 2021, then soared 84.54% in 2025.
  • Over 5 years, Free Cash Flow stood at -$30.5 million in 2021, then tumbled by 38.43% to -$42.3 million in 2022, then skyrocketed by 47.45% to -$22.2 million in 2023, then rose by 25.58% to -$16.5 million in 2024, then soared by 41.06% to -$9.7 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$9.7 million, -$6.5 million, and -$5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.